7,150 件 ・ 関連度順
概要と使いどころ
Analyze Microsoft Outlook PST and OST files for email forensic evidence including message content, headers, attachments, deleted items, and metadata using libpff, pst-utils, and forensic email analysis tools for legal investigations and incident response.
日本語の概要は準備中です。原文の説明を表示しています。
Parse Windows Prefetch files to determine program execution history including run counts, timestamps, and referenced files for forensic investigation.
日本語の概要は準備中です。原文の説明を表示しています。
Parse NetFlow v9 and IPFIX records to detect volumetric anomalies, port scanning, data exfiltration, and C2 beaconing patterns. Uses the Python netflow library to decode flow records, builds traffic baselines, and applies statistical analysis to identify flows with abnormal byte counts, connection durations, and periodic timing patterns.
日本語の概要は準備中です。原文の説明を表示しています。
Use the Malpedia platform and API to research malware family relationships, track variant evolution, link families to threat actors, and integrate YARA rules for detection across malware lineages.
日本語の概要は準備中です。原文の説明を表示しています。
Investigate compromised Docker containers by analyzing images, layers, volumes, logs, and runtime artifacts to identify malicious activity and evidence.
日本語の概要は準備中です。原文の説明を表示しています。
Comprehensive document creation, editing, and analysis with support for tracked changes, comments, formatting preservation, and text extraction. When Claude needs to work with professional documents (.docx files) for: (1) Creating new documents, (2) Modifying or editing content, (3) Working with tracked changes, (4) Adding comments, or any other document tasks
日本語の概要は準備中です。原文の説明を表示しています。
Parses API Gateway access logs (AWS API Gateway, Kong, Nginx) to detect BOLA/IDOR attacks, rate limit bypass, credential scanning, and injection attempts. Uses pandas for statistical analysis of request patterns and anomaly detection. Use when investigating API abuse or building API-specific threat detection rules.
日本語の概要は準備中です。原文の説明を表示しています。
Presentation creation, editing, and analysis. When Claude needs to work with presentations (.pptx files) for: (1) Creating new presentations, (2) Modifying or editing content, (3) Working with layouts, (4) Adding comments or speaker notes, or any other presentation tasks
日本語の概要は準備中です。原文の説明を表示しています。
Frequency-domain and signal-processing skill; use when working on Fourier, spectral, or resonance analysis.
日本語の概要は準備中です。原文の説明を表示しています。
Create new skills, modify and improve existing skills, and measure skill performance. Use when users want to create a skill from scratch, edit, or optimize an existing skill, run evals to test a skill, benchmark skill performance with variance analysis, or optimize a skill's description for better triggering accuracy.
日本語の概要は準備中です。原文の説明を表示しています。
Algorithm design and analysis skill for DSH; use when working on optimization, data structures, or computational procedures.
日本語の概要は準備中です。原文の説明を表示しています。
Create new skills, modify and improve existing skills, and measure skill performance. Use when users want to create a skill from scratch, edit, or optimize an existing skill, run evals to test a skill, benchmark skill performance with variance analysis, or optimize a skill's description for better triggering accuracy.
日本語の概要は準備中です。原文の説明を表示しています。
Guides experiment state transitions: launching, pausing, resuming, ending, shipping variants, archiving, resetting, duplicating, and copying to another project. Covers preconditions, implications for variant assignment and analysis, and the decision framework for when to use each action. TRIGGER when: user asks to launch, pause, resume, end, ship, archive, reset, duplicate, or copy an experiment to another project. DO NOT TRIGGER when: user is creating an experiment (use creating-experiments), configuring rollout (use configuring-experiment-rollout), or setting up metrics (use configuring-experiment-analytics).
日本語の概要は準備中です。原文の説明を表示しています。
Diagnose why a product metric changed (dropped, spiked, or plateaued) by orchestrating breakdowns, actors, paths, lifecycle, retention, and annotations queries. Use when the user reports an anomaly, asks "why did X change?", or needs root-cause analysis for a trend, funnel, retention, stickiness, or lifecycle metric.
日本語の概要は準備中です。原文の説明を表示しています。
Assesses what a page's heatmap is telling you and recommends concrete changes. Pulls click / rageclick / scroll-depth data for a URL, names the hot elements by cross-referencing autocapture events on the same page, and can create a saved heatmap the user opens in PostHog, then summarizes the behavior and proposes improvements. TRIGGER when: user asks what a heatmap shows, why people aren't clicking something, where users rage-click, how far they scroll, what to change on a page based on heatmap/click data, or to 'analyze/assess/review the heatmap' for a URL. DO NOT TRIGGER when: the user only wants to create a saved heatmap screenshot with no analysis (use heatmaps-saved-create directly), or is asking about session replay in general (use investigating-replay).
日本語の概要は準備中です。原文の説明を表示しています。
Configures the analytics side of a PostHog experiment — exposure criteria (default `$feature_flag_called` vs custom exposure events), primary and secondary metrics, the supported metric types (count, sum, ratio with `math` and `math_property`, retention with `retention_window_start` and `start_handling`), multivariate user handling ("Exclude" vs "First seen variant"), and how to read results once the experiment is live. Use when the user adds or edits a primary or secondary metric (e.g. "add a secondary metric tracking 'downloaded_file' per user"), sets up a ratio metric (e.g. "revenue from purchase_completed / pageviews"), sets up a retention metric (e.g. "$pageview → uploaded_file, 7-day window"), configures custom exposure (e.g. "only count users who hit /checkout"), changes multivariate handling, or asks "who is in the analysis?", "how do I measure impact?", "is this winning?", "what's the confidence level?", or "should I ship?".
日本語の概要は準備中です。原文の説明を表示しています。
Monte Carlo simulation for statistical mechanics — Ising model, Metropolis-Hastings, Wolff cluster algorithm, observables (magnetization, susceptibility, specific heat), finite-size scaling, and critical phenomena analysis.
日本語の概要は準備中です。原文の説明を表示しています。
Estimates the minimum biological replicates (or cells/events) for a target power at a target FDR in genomics experiments using ssizeRNA, PROPER, powsimR for scRNA-seq, and pilot-data dispersion estimation from DESeq2/edgeR. Covers the biological-versus-technical replication distinction (technical replicates do not add degrees of freedom for biological inference), replicate-number-versus-sequencing-depth budgeting, scRNA-seq sample-versus-cell allocation under a pseudobulk model, and the critique that "n=3" is a publication convention rather than a power calculation. Use when budgeting a sequencing experiment, writing the sample-size justification in a grant, estimating replicates from pilot data, allocating a fixed budget between samples and depth, or planning scRNA-seq cohort size. For clinical-trial sample size see clinical-biostatistics/power-and-sample-size; for the power-given-n direction see experimental-design/power-analysis.
日本語の概要は準備中です。原文の説明を表示しています。
Prepares statistical reports for clinical trials following CONSORT 2025, SPIRIT 2025, ICH E9(R1) estimands, and FDA 2023 covariate adjustment guidance. Covers Table 1 generation, analysis populations (ITT/FAS/PP/Safety), the 5 ICH E9(R1) intercurrent-event strategies, MMRM under MAR (mmrm), reference-based MI (rbmi J2R/CR/CIR), Permutt tipping-point sensitivity, and Rubin's-rules vs frequentist variance debate. Use when preparing regulatory submissions, defining estimands, or implementing missing-data sensitivity analyses.
日本語の概要は準備中です。原文の説明を表示しています。
Structures biological experiments so inference is valid by construction, covering Fisher's principles (randomization, replication, local control), the experimental-vs-observational unit distinction and pseudoreplication (Hurlbert 1984; Lazic 2018), randomization mechanics (complete, restricted, stratified, rerandomization, run-order), blocking layouts (randomized complete block, Latin square, incomplete block), factorial designs and interactions, and the split-plot/nested error strata hidden inside multi-batch genomics. Use when deciding the experimental unit and what counts as a replicate, planning randomization and run order, choosing a blocked/factorial/split-plot/nested layout, avoiding pseudoreplication in cell-culture or animal studies, or specifying the random-effects structure of the analysis model. For assigning samples to sequencing batches/lanes/plates and batch-effect correction see experimental-design/batch-design; for regulated clinical-trial randomization see clinical-biostatistics.
日本語の概要は準備中です。原文の説明を表示しています。
Strategic clinical trial design feasibility assessment. Analyzes 6 dimensions (endpoint, population, comparator, effect size, duration, regulatory pathway) using precedent trials and FDA guidance. Produces enrollment projections, endpoint recommendations, and approval-pathway analysis. Use for trial-protocol design, power/sample-size estimation, comparator selection, and FDA submission strategy. Driven by precedent-based reasoning rather than first-principles math.
日本語の概要は準備中です。原文の説明を表示しています。
Calculates statistical power for high-dimensional genomics experiments (bulk RNA-seq, scRNA-seq, ATAC-seq, ChIP-seq, methylation, proteomics) under negative-binomial count models using RNASeqPower, PROPER, and simulation via powsimR, distinguishing per-gene from marginal (transcriptome-wide) power, the role of mean expression and dispersion, and the sequencing-depth-versus-replicate tradeoff. Covers simulation as the honest default for overdispersed counts, FDR-aware average power versus single-test power, observed/post-hoc power as an anti-pattern, and the winner's-curse / Type-S / Type-M consequences of underpowering. Use when planning replicate number for a sequencing experiment, deciding whether to add depth or samples, choosing closed-form versus simulation power, estimating power from pilot dispersions, or justifying replication in a grant. For clinical-trial power see clinical-biostatistics/power-and-sample-size; for the inverse sample-size question see experimental-design/sample-size.
日本語の概要は準備中です。原文の説明を表示しています。
Performs subgroup and heterogeneous treatment effect (HTE) analyses for clinical trials. Covers Mantel-Haenszel pooling, Breslow-Day, interaction tests in regression, RERI for additive interaction, modern data-adaptive HTE methods (STEPP, SIDES, causal forests, X/R-learners), Bayesian shrinkage (Dixon-Simon, MAP, EXNEX), graphical multiplicity (Bretz-Maurer), and credibility frameworks (Sun BMJ, EMA 2019). Use when analyzing treatment effects across patient subgroups for regulatory submissions or precision-medicine claims.
日本語の概要は準備中です。原文の説明を表示しています。
Designs genomics experiments so technical nuisance variation (batch, lane, plate, flow cell, operator, reagent lot, processing day) is balanced against the biological variable of interest and therefore estimable rather than confounded, using constrained sample-to-batch assignment (designit, OSAT), the confounder/mediator/collider distinction, and the principle that no post-hoc correction recovers a fully confounded design. Covers detecting hidden batches with surrogate variable analysis, a decision table for downstream correction (ComBat-seq, RUVSeq, SVA) whose execution is deferred to differential-expression/batch-correction, and reproducibility metadata. Use when assigning samples to sequencing batches/lanes/plates, avoiding batch-condition confounding, deciding whether a design is salvageable by correction, choosing a correction method, or estimating the number of hidden batches. For the experimental unit, randomization, and blocking concepts see experimental-design/randomization-blocking.
日本語の概要は準備中です。原文の説明を表示しています。